Serotonin 5-HT2 Receptor Agonists

DBCAT001689Pharmacologic class

Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT2 RECEPTORS. Included under this heading are agonists for one or more of the specific 5-HT2 receptor subtypes. A DrugBank category of 17 drugs. 9 of them are approved.

Part of: Serotonin Receptor Agonists
Also known as: 5 HT2 Agonist · 5 HT2 Agonists · 5-HT2 Agonist · 5-HT2 Agonists · Agonist, 5-HT2
Drugs: 2,5-Dimethoxy-4-ethylthioamphetamine
5-methoxy-N,N-dimethyltryptamine
Bromocriptine
Cabergoline
Cannabidiol
Dihydroergotamine
Ergotamine
Fenfluramine
Lofexidine
Lorcaserin
Lysergic acid diethylamide
m-Chlorophenylpiperazine
Midomafetamine
MMDA
N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine
Pergolide
Vabicaserin

What you can answer from here — as of October 27, 2022

17DrugsEach linked to its full drug card

Listed above

76Drug targetsEvery drug–target pair in the class, with bond type

737Marketed productsAcross the regions we cover, with dosage forms and routes

10Routes of administrationHow the drugs in this class are given

3SubcategoriesNarrower classes within this one

Which targets do Serotonin 5-HT2 Receptor Agonists share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account